Akshaya BIO logo

Akshaya BIO

Flexible platform vaccine technology designed to elicit both humoral and cellular immune responses in hosts

1

Funding Rounds

$7.5m

Money raised

Overview

Flexible platform vaccine technology designed to elicit both humoral and cellular immune responses in hosts

Funding series

Funding Series Analysis

The company Akshaya BIO has raised a total of $7.5m in funding over 1 rounds.

Key Insights:

  • Autofleet Funding Round 2020: $7.5m
Akshaya BIO logo
Autofleet Funding Round 2020 $7.5m

Industries

Akshaya BIO is active in the following industries: